Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028

Report Code : TIPRE00004548 | Region : Global | Industry : Biotechnology | Published Date : 17/Jan/2022
Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Methods, and CTC Analysis), Application (Clinical/Liquid Biopsy and Research), and End User (Hospital and Clinics, Research and Academic Institutes, and Diagnostic Centers)

The global circulating tumor cell (CTC) diagnostics market is projected to reach US$ 1,909.41 million by 2028 from US$ 3,656.38 million in 2021; it is expected to grow at a CAGR of 9.7% during 2021-2028. The market growth is mainly attributed to the increasing prevalence of cancer globally.

A circulating tumor cell (CTC) is a cell that sheds into lymphatics from the primary tumor and carried out throughout the body with blood circulation. Circulating tumor cells are the seeds for growth and metastases for additional tumors in distant organs and is responsible for majority of cancer-related deaths. The diagnosis, detection, and analysis of CTC can assist in patients’ prognoses determine appropriate tailored treatments for the patients. The CTC diagnosis has a lot of advantages for traditional diagnostic procedures. It is a noninvasive and effective process that can be used repeatedly. CTC detection and enrichment, CTC direct detection, and CTC analysis are among the major technologies.

Health systems across the globe are witnessing a substantial increase in the prevalence of cancer. According to the World Health Organization, cancer is the second-leading cause of mortality worldwide. The global cancer burden has increased to 19.3 million cases and 9.96 million cancer deaths by 2020, according to the International Agency for Research on Cancer (IARC).

According to a study published by the National Cancer Institute, cancer incidence in the US is likely to reach 1.9 million in 2021. Around 0.6 million people were anticipated to die in 2021 in the US due to cancer. Moreover, according to data published by Cancer Research UK in 2020, around 0.16 million people in the UK die each year due to cancer. As per the Globocan report, in 2018, there were 911,014 breast cancer cases and 310,577 deaths due to breast cancer, of which 367,900 and 162,468 breast cancer cases were reported in China and India, respectively. Thus, the increased prevalence of cancer across the globe is propelling the demand for circulating tumor cell diagnostics.

The analysis and detection of circulating tumor cells assist in early patient diagnosis and prognosis help determine accurate treatment for the patient. The CTC diagnostics are used in various types of cancers, including prostate cancer, breast cancer, colorectal cancer, kidney cancer, lymphomas, lung cancer, and melanoma. There has been a high demand for CTC diagnostics in recent years due to its reliability and accuracy in identifying the risk of various cancers and monitoring different cancer treatments.

Technology Insights

Based on technology, the global circulating tumor cell (CTC) diagnostics market is segmented into CTC detection and enrichment method, CTC direct detection method, and CTC analysis. In 2020, the CTC detection and enrichment method segment held the largest share of the market. However, the same segment is expected to register the highest CAGR during 2021-2028. An enrichment stage, if done properly, can enhance selectivity, sensitivity, and yield. Also, most crucially, it can cut the time taken to isolate rare circulating tumor cells to half. Therefore, various advantages offered by enrichment technique are expected to drive the market during the forecast period.

Application Insights

Based on application, the global circulating tumor cell (CTC) diagnostics market is bifurcated into clinical/liquid biopsy and research. In 2020, the research segment held a larger share of the market and is expected to register a higher CAGR in the market during 2021-2028. The detection of CTCs in blood samples is becoming one of the most active areas of translational cancer research. Therefore, the rising demand for new diagnostic and treatment methods for cancer is expected to drive the market during the forecast period.

End-User Insights

Based on end-users, the circulating tumor cell (CTC) diagnostics market is segmented into hospitals and clinics, research and academic institutes, and diagnostic centers. The research and academic institutes segment held the largest market share in 2021. However, the same segment is expected to hold a significant market share in the market during the forecast period. The increasing research surrounding cancer diagnosis and therapeutic development, growing awareness for cancer diagnosis, and high investment from government and other enterprises are a few of the critical factors supporting the growth of the cancer research institutes segment.

A few major primary and secondary sources referred to while preparing the report on the global circulating tumor cell (CTC) diagnostics market are the Global Cancer Observatory, World Bank Data, International Health Regulation, International Agency for Research on Cancer (IARC), National Cancer Institute, Cancer Research UK, and World Bank Data.

The List of Companies - Circulating Tumor Cell (CTC) Diagnostics Market

1. Thermo Fisher Scientific Inc.

2. STEMCELL Technologies Inc.

3. QIAGEN

4. Precision Medicine Group, LLC.

5. Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)

6. Epic Sciences

7. ScreenCell

8. Ikonisys, Inc.

9. IVDiagnostics

10. Fluxion Biosciences Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Circulating Tumor Cell (CTC) Diagnostics Market – By Technology

1.3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market – By Application

1.3.3 Global Circulating Tumor Cell (CTC) Diagnostics Market – By End-User

1.3.4 Global Circulating Tumor Cell (CTC) Diagnostics Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East and Africa PEST Analysis

4.2.5 South and Central America PEST Analysis

4.3 Experts Opinion

5. Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Cancer Globally

5.1.2 Rising Demand for Minimally Invasive Diagnostic Procedures

5.2 Market Restraints

5.2.1 Rising Dearth of Skilled Professionals Performing Diagnostic Procedures

5.3 Market Opportunities

5.3.1 Untapped Potential of Emerging Economies

5.4 Future Trends

5.4.1 Technological Advancements in Isolation of Circulating Tumor Cell

5.5 Impact Analysis

6. Circulating Tumor Cell (CTC) Diagnostics Market– Global Analysis

6.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis

6.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis

6.3 Market Positioning of Key Players

7. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 – Technology

7.1 Overview

7.2 Global Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2021 & 2028 (%)

7.3 CTC detection and Enrichment Method

7.3.1 Overview

7.3.2 CTC detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4 CTC Direct Detection Method

7.4.1 Overview

7.4.2 CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5 CTC Analysis

7.5.1 Overview

7.5.2 CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 – Application

8.1 Overview

8.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application - 2021 & 2028 (%)

8.3 Clinical/Liquid Biopsy

8.3.1 Overview

8.3.2 Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3 Risk Assessment

8.3.3.1 Overview

8.3.3.2 Risk Assessment : Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4 Screening and Monitoring

8.3.4.1 Overview

8.3.4.2 Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Research

8.4.1 Overview

8.4.2 Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.1 Cancer Stem Cell & Tumorigenesis Research

8.4.2.1.1 Overview

8.4.2.1.2 Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.2 Drug/Therapy Development

8.4.2.2.1 Overview

8.4.2.2.2 Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 – End user

9.1 Overview

9.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2021 & 2028 (%)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Research and Academic Institutes

9.4.1 Overview

9.4.2 Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5 Diagnostic Centers

9.5.1 Overview

9.5.2 Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Global Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis

10.1 North America: Circulating Tumor Cell (CTC) Diagnostics Market

10.1.1 Overview

10.1.2 North America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)

10.1.4 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)

10.1.4.1 North America Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.4.2 North America Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.5 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)

10.1.6 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3 US: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)

10.1.6.1.4 US: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)

10.1.6.1.4.1 US Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.6.1.4.2 US Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.6.1.5 US: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)

10.1.7 Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.7.1.1 Overview

10.1.7.1.2 Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.7.1.3 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)

10.1.7.1.4 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)

10.1.7.1.4.1 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.7.1.4.2 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.7.1.5 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)

10.1.7.2 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.7.2.1 Overview

10.1.7.2.2 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.7.2.3 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)

10.1.7.2.4 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)

10.1.7.2.4.1 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.7.2.4.2 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.7.2.5 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)

10.2 Europe: Circulating Tumor Cell (CTC) Diagnostics Market

10.2.1 Overview

10.2.2 Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.4 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.4.1 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.2.4.2 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)

10.2.5 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.1 Overview

10.2.6.1.2 Germany: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.3 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.4 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.4.1 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.2.6.1.4.2 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.2.6.1.5 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2 France: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.1 Overview

10.2.6.2.2 France: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.3 France: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.4 France: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.4.1 France: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)

10.2.6.2.4.2 France: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)

10.2.6.2.5 France: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3 UK: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.1 Overview

10.2.6.3.2 UK: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.3 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.4 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.4.1 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.2.6.3.4.2 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.2.6.3.5 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4 Italy: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.1 Overview

10.2.6.4.2 Italy: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.3 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.4 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.4.1 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)

10.2.6.4.4.2 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.2.6.4.5 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5 Spain: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.1 Overview

10.2.6.5.2 Spain: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.3 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.4 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.4.1 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.2.6.5.4.2 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.2.6.5.5 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.1 Overview

10.2.6.6.2 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.3 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.4 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.4.1 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.2.6.6.4.2 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.2.6.6.5 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market

10.3.1 Overview

10.3.2 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.3.3 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)

10.3.4 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)

10.3.4.1 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)

10.3.4.2 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)

10.3.5 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)

10.3.6 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.3.6.1 China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.1 China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.1.2 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)

10.3.6.1.3 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)

10.3.6.1.3.1 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)

10.3.6.1.3.2 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)

10.3.6.1.4 China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)

10.3.6.2 Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.1 Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.2.2 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)

10.3.6.2.3 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)

10.3.6.2.3.1 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)

10.3.6.2.3.2 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)

10.3.6.2.4 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)

10.3.6.3 India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.1 India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.3.2 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)

10.3.6.3.3 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)

10.3.6.3.3.1 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)

10.3.6.3.3.2 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)

10.3.6.3.4 India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)

10.3.6.4 Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.1 Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.4.2 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)

10.3.6.4.3 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)

10.3.6.4.3.1 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)

10.3.6.4.3.2 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)

10.3.6.4.4 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)

10.3.6.5 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.1 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.5.2 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)

10.3.6.5.3 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)

10.3.6.5.3.1 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)

10.3.6.5.3.2 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)

10.3.6.5.4 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)

10.3.6.6 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.1 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.3.6.6.2 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)

10.3.6.6.3 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)

10.3.6.6.3.1 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)

10.3.6.6.3.2 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)

10.3.6.6.4 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)

10.4 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028

10.4.1 Overview

10.4.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.3 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.4 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.4.4.1 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.4.4.2 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.4.5 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.6 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

10.4.6.1 UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.1.1 Overview

10.4.6.1.2 UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.1.3 UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.6.1.4 UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.1.4.1 UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)

10.4.6.1.4.2 UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)

10.4.6.1.5 UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.2.1 Overview

10.4.6.2.2 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.2.3 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.6.2.4 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.2.4.1 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)

10.4.6.2.4.2 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)

10.4.6.2.5 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.3.1 Overview

10.4.6.3.2 South Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.3.3 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.6.3.4 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.3.4.1 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)

10.4.6.3.4.2 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)

10.4.6.3.5 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4 Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.4.1 Overview

10.4.6.4.2 Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.4.3 Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.6.4.4 Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.4.4.1 Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)

10.4.6.4.4.2 Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.4.6.4.5 Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market

10.5.1 Overview

10.5.2 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5.3 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.5.4 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.5.4.1 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.5.4.2 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.5.5 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

10.5.6 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.5.6.1 Brazil

10.5.6.1.1 Overview

10.5.6.1.2 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.4 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.4.1 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.4.2 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.5 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

10.5.6.2 Argentina

10.5.6.2.1 Overview

10.5.6.2.2 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.4 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.4.1 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.4.2 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.5 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3 Rest of South and Central America

10.5.6.3.1 Overview

10.5.6.3.2 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.3 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.4 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.4.1 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.4.2 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.5 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

11. Impact of COVID-19 Pandemic on Global Circulating Tumor Cell (CTC) Diagnostics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 STEMCELL Technologies Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Precision Medicine Group, LLC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 EPIC SCIENCES, INC.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 SCREENCELL

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 IKONISYS, INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 IVDiagnostics

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 FLUXION BIOSCIENCES

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6. US Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 7. US Circulating Tumor Cell (CTC) Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8. US Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 9. US Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 10. US Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 22. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 23. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 24. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 25. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 26. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 27. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 28. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 29. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 30. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31. France: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 32. France: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 33. France: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 34. France: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 35. France: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 36. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 37. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 38. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 39. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 40. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 41. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 42. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 43. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 44. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 45. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 46. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 47. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 48. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 49. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 50. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 51. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 52. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 53. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 54. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 55. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 56. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 57. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 58. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 59. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 60. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 61. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 62. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 63. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 64. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 65. China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 66. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology– Revenue and Forecast to 2028 (US$ Million)

Table 67. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 68. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 69. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 70. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 71. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology– Revenue and Forecast to 2028 (US$ Million)

Table 72. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application– Revenue and Forecast to 2028 (US$ Million)

Table 73. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/ Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 74. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research– Revenue and Forecast to 2028 (US$ Million)

Table 75. India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User– Revenue and Forecast to 2028 (US$ Million)

Table 76. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 77. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 78. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 79. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 80. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 81. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 82. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 83. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 84. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 85. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 86. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 87. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 88. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 89. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 90. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 91. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 92. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 93. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 94. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 95. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 96. UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 97. UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 98. UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 99. UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 100. UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 101. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 102. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 103. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 104. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 105. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 106. South Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 107. South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 108. South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 109. South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 110. South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 111. Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 112. Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 113. Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 114. Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)

Table 115. Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 116. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 117. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 118. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 119. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 120. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 121. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 122. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 123. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 124. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 125. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 126. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 127. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 128. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 129. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 130. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 131. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 132. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 133. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 134. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 135. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 136. Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 137. Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 138. Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market

The List of Companies - Circulating Tumor Cell (CTC) Diagnostics Market

1. Thermo Fisher Scientific Inc.

2. STEMCELL Technologies Inc.

3. QIAGEN

4. Precision Medicine Group, LLC.

5. Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)

6. Epic Sciences

7. ScreenCell

8. Ikonisys, Inc.

9. IVDiagnostics

10. Fluxion Biosciences Inc.

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the circulating tumor cell (CTC) diagnostics market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global circulating tumor cell (CTC) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry